Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome.

Chang PL, Zeitoun KM, Chan LK, Thornton MH 2nd, Sauer MV.

J Reprod Med. 2002 Apr;47(4):253-8.

PMID:
12012875
3.

Molecular basis for treating endometriosis with aromatase inhibitors.

Bulun SE, Zeitoun KM, Takayama K, Sasano H.

Hum Reprod Update. 2000 Sep-Oct;6(5):413-8.

PMID:
11045871
4.

Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.

Bulun SE, Zeitoun KM, Takayama K, Sasano H.

J Mol Endocrinol. 2000 Aug;25(1):35-42. Review.

PMID:
10915216
5.
6.

Aromatase as a therapeutic target in endometriosis.

Bulun SE, Zeitoun KM, Takayama K, Simpson E, Sasano H.

Trends Endocrinol Metab. 2000 Jan-Feb;11(1):22-7. Review.

PMID:
10652502
7.

Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target.

Zeitoun KM, Bulun SE.

Fertil Steril. 1999 Dec;72(6):961-9. Review.

PMID:
10593363
8.

Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.

Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD.

Fertil Steril. 1999 Nov;72(5):823-9.

PMID:
10560985
9.

Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.

Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE.

J Clin Endocrinol Metab. 1997 Feb;82(2):600-6.

PMID:
9024261

Supplemental Content

Loading ...
Support Center